Cytodyn Inc (CYDY)

[Saltz]

Not a medical professional. However if your invested in Biotech it makes sense one should understand a bit about how the FDA operates. Amateur seems to knows more than most about the process and is a strong asset. He is spot on when he talks about timelines. Almost always much longer than investors perception. So many snags in the process. I'm with you on your optimistic outlook because I think Pro-140 is special. It's up to Nader and his team to navigate the FDA Gauntlet. We are going to find out how the next chapter is going to unfold very soon.

Your comments on the hold on enrollment for the PIII Adjunct makes sense and it is a high probability that we have enough patients or are very close. On the other hand there is the possibility that they stopped enrollment when they requested the Face to Face with the FDA because it was to make a case for relaxing the protocol. Odds are you are right. That will be very good news and BTD will be icing on the cake.